Innoviva (INVA) Net Margin Growth (1y) (2012 - 2026)
Innoviva (INVA) Net Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Innoviva |
1.69 Bn |
1.08 Bn |
75.83 Mn |
24,295.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
24,295.00 |
| Dec 31, 2025 |
-42,065.00 |
| Sep 30, 2025 |
8,206.00 |
| Jun 30, 2025 |
9,823.00 |
| Mar 31, 2025 |
-383,352.00 |
| Dec 31, 2024 |
-42,286.00 |
| Sep 30, 2024 |
-12,063.00 |
| Jun 30, 2024 |
-16,533.00 |
| Mar 31, 2024 |
-59,907.00 |
| Dec 31, 2023 |
55,219.00 |
| Sep 30, 2023 |
-2.03 Mn |
| Jun 30, 2023 |
8,075.00 |
| Mar 31, 2023 |
310,389.00 |
| Dec 31, 2022 |
-37,116.00 |
| Sep 30, 2022 |
2.04 Mn |
| Jun 30, 2022 |
-756,554.00 |
| Mar 31, 2022 |
-755,342.00 |
| Dec 31, 2021 |
-1.13 Mn |
| Sep 30, 2021 |
4,221.00 |
| Jun 30, 2021 |
751,807.00 |
